BACKGROUND & AIMS: Interleukin-6 (IL-6) is a crucial factor in liver regeneration following partial hepatectomy (PH); however, the role of IL-6 and IL-6 trans-signaling in particular, in hepatocyte mitosis remains controversial. IL-6 trans-signaling relies upon the release of the soluble IL-6R (sIL-6R), which binds IL-6 to form an agonistic IL-6/sIL-6R complex. Herein we have examined the hypothesis that IL-6 trans-signaling plays a crucial and distinct role in liver regeneration following PH. METHODS: The specific IL-6/sIL-6R antagonist, sgp130Fc, was expressed in mice and analyzed for its effect on hepatocyte mitosis following PH. Alternatively, we examined the effect of the IL-6/sIL-6R super-agonist, Hyper-IL-6, or IL-6 expressed either alone or in combination with hepatocyte growth factor (HGF) on hepatocyte mitosis in the absence of PH. RESULTS: Following PH, the dramatic rise of circulating IL-6 levels is accompanied by a concurrent ∼2-fold increase in circulating sIL-6R levels. Ectopic expression of sgp130Fc reduced hepatocyte mitosis by about 40% at early times following PH, while substantially reducing AKT, but not STAT3, activation. But, ectopic Hyper-IL-6 expression in mice without PH was not mitogenic to hepatocytes in vivo. Rather, Hyper-IL-6, but not IL-6, markedly increased HGF-induced hepatocyte mitosis. This cooperative effect correlated with greater resistance of HIL-6 than IL-6 to HGF-mediated reduction of AKT activation, rather than changes in STAT3 or MAPK signaling, and was completely blocked by PI3K inhibition. CONCLUSIONS: Following PH, IL-6/sIL-6R cooperates with growth factors, through a PI3K/AKT-dependent mechanism to promote entry of hepatocytes into the cell cycle.
BACKGROUND & AIMS:Interleukin-6 (IL-6) is a crucial factor in liver regeneration following partial hepatectomy (PH); however, the role of IL-6 and IL-6 trans-signaling in particular, in hepatocyte mitosis remains controversial. IL-6 trans-signaling relies upon the release of the soluble IL-6R (sIL-6R), which binds IL-6 to form an agonistic IL-6/sIL-6R complex. Herein we have examined the hypothesis that IL-6 trans-signaling plays a crucial and distinct role in liver regeneration following PH. METHODS: The specific IL-6/sIL-6R antagonist, sgp130Fc, was expressed in mice and analyzed for its effect on hepatocyte mitosis following PH. Alternatively, we examined the effect of the IL-6/sIL-6R super-agonist, Hyper-IL-6, or IL-6 expressed either alone or in combination with hepatocyte growth factor (HGF) on hepatocyte mitosis in the absence of PH. RESULTS: Following PH, the dramatic rise of circulating IL-6 levels is accompanied by a concurrent ∼2-fold increase in circulating sIL-6R levels. Ectopic expression of sgp130Fc reduced hepatocyte mitosis by about 40% at early times following PH, while substantially reducing AKT, but not STAT3, activation. But, ectopic Hyper-IL-6 expression in mice without PH was not mitogenic to hepatocytes in vivo. Rather, Hyper-IL-6, but not IL-6, markedly increased HGF-induced hepatocyte mitosis. This cooperative effect correlated with greater resistance of HIL-6 than IL-6 to HGF-mediated reduction of AKT activation, rather than changes in STAT3 or MAPK signaling, and was completely blocked by PI3K inhibition. CONCLUSIONS: Following PH, IL-6/sIL-6R cooperates with growth factors, through a PI3K/AKT-dependent mechanism to promote entry of hepatocytes into the cell cycle.
Authors: Andrew M Hoffman; Julia A Paxson; Melissa R Mazan; Airiel M Davis; Shivraj Tyagi; Shankar Murthy; Edward P Ingenito Journal: Stem Cells Dev Date: 2011-07-06 Impact factor: 3.272
Authors: Yongjie Zhou; Lei Zhang; Hongjie Ji; Xufeng Lu; Jie Xia; Li Li; Fei Chen; Hong Bu; Yujun Shi Journal: J Cell Mol Med Date: 2016-01-19 Impact factor: 5.310
Authors: H Kuroki; H Hayashi; S Nakagawa; K Sakamoto; T Higashi; H Nitta; D Hashimoto; A Chikamoto; T Beppu; H Baba Journal: Br J Surg Date: 2015-04-13 Impact factor: 6.939
Authors: Jinrui Dong; Sivakumar Viswanathan; Eleonora Adami; Sebastian Schafer; Fathima F Kuthubudeen; Anissa A Widjaja; Stuart A Cook Journal: Elife Date: 2021-08-26 Impact factor: 8.140
Authors: Maria D Giraldez; David Carneros; Christoph Garbers; Stefan Rose-John; Matilde Bustos Journal: Nat Rev Gastroenterol Hepatol Date: 2021-07-01 Impact factor: 46.802
Authors: Svantje Sobotta; Andreas Raue; Xiaoyun Huang; Joep Vanlier; Anja Jünger; Sebastian Bohl; Ute Albrecht; Maximilian J Hahnel; Stephanie Wolf; Nikola S Mueller; Lorenza A D'Alessandro; Stephanie Mueller-Bohl; Martin E Boehm; Philippe Lucarelli; Sandra Bonefas; Georg Damm; Daniel Seehofer; Wolf D Lehmann; Stefan Rose-John; Frank van der Hoeven; Norbert Gretz; Fabian J Theis; Christian Ehlting; Johannes G Bode; Jens Timmer; Marcel Schilling; Ursula Klingmüller Journal: Front Physiol Date: 2017-10-09 Impact factor: 4.566